Nxera Pharma
4565.T
$5.13
Share price
9.46%
Change (1 day)
-52.01%
Change (1 year)
Categories
Revenue for Nxera Pharma (4565.T)
Revenue in 2024 (TTM): $0.15 Billion USD
According to Nxera Pharma's latest financial reports the company's current revenue (TTM 
) is $0.15 Billion USD. In 2023 the company made a revenue of $89.37 Million USD a decrease over the revenue in the year 2022 that were of $0.11 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nxera Pharma from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $0.15 B | 73.24% |
| 2023 | $89.37 M | -22.1% |
| 2022 | $0.11 B | -26.07% |
| 2021 | $0.15 B | 84.22% |
| 2020 | $84.23 M | -5.42% |
| 2019 | $89.06 M | 177.26% |
| 2018 | $32.12 M | -55.26% |
| 2017 | $71.8 M | -57.46% |
| 2016 | $0.16 B | 94.22% |
| 2015 | $86.91 M | 713.89% |
| 2014 | $10.67 M | -45.63% |
| 2013 | $19.64 M | -16.03% |
| 2012 | $23.38 M | 118.8% |
| 2011 | $10.68 M | 23.2% |
| 2010 | $8.67 M | -6.82% |
| 2009 | $9.31 M |